Lymphomas of different histological types can occur at the same anatomical site (composite lymphoma) or at different sites, and can arise simultaneously or sequentially \[[@B1], [@B2]\]. Reports of patients in whom histologically distinct lymphomas occur simultaneously at different sites are rare \[[@B3], [@B4]\]. Among these rare cases, the simultaneous occurrence of T- and B-cell lymphomas is extremely rare \[[@B5]\]. To the best of our knowledge, composite involvement of T- and B-cell lymphomas in the bone marrow (BM) have not been reported so far. We report a case of composite BM involvement by T- and B-cell lymphomas.

A 52-yr-old woman presented with abdominal discomfort. She had a history of hepatitis B-related liver cirrhosis and was taking lamivudine. She had lost 4 kg of weight in the previous 4 months. Laboratory investigation revealed pancytopenia (white blood cells, 1.7×10^9^/L \[reference range: 4-10×10^9^/L\]; hemoglobin, 11.0 g/dL \[12-16 g/dL\]; and platelets, 75×10^9^/L \[150-350×10^9^/L\]), elevated levels of liver enzymes (aspartate transaminase, 75 IU/L \[0-40 IU/L\]; alkaline phosphatase, 129 IU/L \[40-120 IU/L\]; γ-glutamyltransferase, 99 IU/L \[8-35 IU/L\]), and an increased level of lactate dehydrogenase (315 IU/L \[120-250 IU/L\]). Dynamic computed tomography revealed an ill-defined, 3-cm lesion in the left lateral segment of the liver and multiple abdominal and mediastinal lymphadenopathies. Esophagogastroduodenoscopy revealed a 3-cm ulcerofungating mass between the antrum and the lower body of the stomach. A liver core needle biopsy identified a peripheral T-cell lymphoma, not otherwise specified, and an endoscopic biopsy of the stomach identified a diffuse large B-cell lymphoma (DLBL). A BM biopsy revealed BM involvement by DLBL with a nodular infiltration pattern, which was corroborated by positive immunohistochemical staining for CD3 and CD20. CD20-positive lymphocytes were present in nodular aggregates. CD3-positive lymphocytes were present in small lymphocytes surrounding CD20-positive lymphocytes suggesting reactive T lymphocytes. A cytogenetic study of BM revealed an apparently normal karyotype. The patient was started on the combination chemotherapy regimen including rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP).

After 6 cycles of R-CHOP, the liver mass and lymphadenopathies had disappeared. However, a follow-up BM biopsy revealed BM involvement by T-cell lymphoma and DLBL. Immunohistochemical staining showed medium to large sized PAX5-positive lymphocytes with a marked interstitial infiltration pattern ([Fig. 1A, B](#F1){ref-type="fig"}), and the cells were also CD79a-positive. Peritrabecular and interstitial infiltration of small to medium sized CD3-positive lymphocytes was also prominent ([Fig. 1C, D](#F1){ref-type="fig"}). Rearrangements of the T-cell receptor gamma locus (*TRG*) and immunoglobulin heavy locus (*IGH*) were studied in BM (after the 6th cycle of R-CHOP), liver, and stomach (at diagnosis) specimens using the BIOMED-2 multiplex PCR protocol \[[@B6]\]. A 170-bp monoclonal *TRG* rearrangement was detected in the liver sample ([Fig. 2A](#F2){ref-type="fig"}), while *TRG* in the BM had a larger 160-bp peak with a smaller 170-bp peak ([Fig. 2B](#F2){ref-type="fig"}). *IGH* gene rearrangements were not detected in the stomach sample or in the BM aspirate, and the BM aspirate had a normal karyotype. After the 8th R-CHOP cycle, computed tomography and positron emission tomography findings suggested involvement of multiple lymph nodes (celiac, splenic hilar, and abdominal paraaortic lymph nodes). The patient died of pneumonia 1 yr after diagnosis.

In our *TRG* rearrangement study, monoclonal *TRG* rearrangements were detected in both liver and BM samples, but the sizes of amplicons were slightly different, that is a finding that may be explained by clonal evolution \[[@B7]\]. We speculate that there is BM involvement on the basis of a subclone from the hepatic T-cell lymphoma. Moreover, a small peak corresponding to a 170-bp PCR product was observed in a BM sample, which suggests that the same clone present in the liver sample was also present in the BM sample. Monoclonal *IGH* rearrangements were not detected in the stomach or BM sample. As monoclonal *IGH* rearrangements are detected in approximately 80% of DLBL cases using BIOMED-2 multiplex PCR \[[@B8]\], the fact that rearrangement of *IGH* was not detected in the stomach sample is not unusual.

T- and B-cell lymphomas simultaneously developed in this patient. Moreover, a follow-up examination suggested BM involvement by both these lymphomas. To our knowledge, this is the first report of a patient with BM involvement by both T- and B-cell lymphomas. Factors contributing to the development of synchronous primary lymphomas have not been investigated, and a case with involvement of the same site by two different lymphomas has not been reported; however, primary composite lymphomas have been reported \[[@B9]\]. The clinical significance of BM involvement by both T- and B-cell lymphomas is unknown, although the simultaneous development of more than one histological type of lymphoma is associated with a poor prognosis \[[@B1]\]. The present patient died 1 yr after her diagnosis, suggesting that composite BM involvement may also be associated with a poor prognosis.
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![Bone marrow biopsy after 6 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) combination chemotherapy. (A, B) Neoplastic B lymphocytes infiltrating in an interstitial pattern was immunohistochemically analyzed by anti-PAX5 antibody (A, ×100; B, ×1,000). (C, D) Neoplastic T lymphocytes infiltrating with a peritrabecular or interstitial pattern was immunohistochemically analyzed by anti-CD3 antibody (C, ×100; D, ×1,000).](alm-35-152-g001){#F1}

![T cell receptor gamma locus (*TRG*) rearrangement analyzed by using BIOMED-2 multiplex PCR. Horizontal axis represents amplicon size (base pairs) and vertical axis represents fluorescence intensity. (A) A monoclonal *TRG* rearrangement was detected at 170 bp in the liver sample. (B) Both a larger peak (160 bp) and a smaller peak (170 bp) were observed in the bone marrow aspirate sample by GeneScan analysis of the PCR results.](alm-35-152-g002){#F2}
